|
C. (P.)
|
|
|
Ðåäàêö³éíà ðàäà (Editorial Board)
|
1
|
|
|
Çì³ñò
(Contents)
|
2-6
|
|
|
ÎÃËßÄÈ (REVIEWS)
|
|
|
|
EXTRACELLULAR DNA IN BACTERIAL BIOFILMS. PART I:
ORIGIN
Krestetska S.L.
Significant
number of chronic bacterial infections involves the biofilm formation, but
regulation of this process is still far from being well understood. Some
progress has been achieved since the reassessment of extracellular DNA (eDNA)
functions in biofilm establishment and remodeling, including influence of
this natural polymeric substance on mechanical stability and adhesiveness of
extracellular polymeric matrix (EPM). As was shown eDNA can appear in EPM at
different stages of biofilm development via different ways, including active
secretion or assimilation from surrounding milieu, but the main source is
widely considered to be induced cell death with subsequent lysis. Cell death
induction as a kind of social behavior in prokaryotes seems to represents an
essential part of the developmental program, clearly associated with a switch
to a sessile community lifestyle and biofilm formation per se. Review is
focused on mechanisms allowing controlled eDNA release, mainly on those
underlying self- or hetero-destructive behavior in bacterial populations.
Keywords:
bacterial biofilms, extracellular DNA, review
|
7-16
|
|
|
«ÊÎÐÎËÜ ÏÐÎÁÈÎÒÈÊλ BACILLUS COAGULANS  ÑÎÂÐÅÌÅÍÍÎÌ
ÊÎÌÁÈÍÈÐÎÂÀÍÍÎÌ ÏÐÎÁÈÎÒÈ×ÅÑÊÎÌ ÏÐÅÏÀÐÀÒÅ ËÀÊÒÎÂÈÒ ÔÎÐÒÅ
(ÏÎËÍÛÉ ÎÁÇÎÐ)
Áîìêî
Ò. Â., Ìàðòûíîâ À. Â., Íîñàëüñêàÿ Ò. Í., Êàáëó÷êî Ò. Â.
«KING OF PROBIOTICS» BACILLUS COAGULANS IN
MODERN COMBINED PROBIOTIC PREPARATIONS LAKTOVIT FORTE (FULL REVIEW)
Bomko T.V., Martynov A.V., Nosalska T.N., Kabluchko
T.V.
Bacillus
coagulans
has an advantage over most other bacteria used as probiotics. It occupies an
intermediate position between the genera Bacillusand Lactobacillus,
is a spore-forming bacteria that produce lactic acid.This bacteria in the
spores form can tolerate well technology processes, resistant to antibiotics
and antiseptics, does not collapse under the influence of gastric juice and
bile. Getting into the duodenum, the spores germinate into vegetative forms
and begin vegetation and growth, providing probiotic effects.Bacillus coagulans refers to semi-residental
bacteria - performing in the human probiotic function, it passes the
sporulation phase and slowly leaves the body, standing out in the faeces in
the spores form. Thus, it does not violate the personal composition of
intestinal microflora.Probiotic Bacillus coagulans enhances the
microbiological composition of the intestine, increasing the number of
obligate microorganisms and displacing pathogenic flora. Mechanisms of this
action based on the lactic acid production and some bacteriocins synthesis,
also on the immunomodulatory effect - stimulation of cellular and humoral
immunity. The bacterial cell wall and spores are the main immunomodulatory
compounds of the Bacillus coagulans.Apparently, namely Bacillus
coagulans immunomodulatory properties play a crucial role in the
pharmacological effects. It is now well known about the important role of
immune system in the pathogenesis of many diseases; it has the clinical
effect without the need for intensive growth of bacteria and intestinal
colonization; even small amounts of spores are sufficient for pharmacological
effect; many experimental evidences of the spore penetration into the
lymphatic system and interaction with immunocompetent cells, as well as local
and systemic immune effects of probiotic.In addition to this main action, Bacillus
coagulans helps to digest lactose, possesses anti-inflammatory and
antioxidant activity, as well as the cholesterol-lowering effect.The
effectiveness of probiotics, containing spores of Bacillus coagulans,
was confirmed by evidence-based medicine. Probiotic effect in the treatment
of various
diarrheas, including those related to antibiotic treatment, enterocolitis and
irritable bowel syndrome. Bacillus coagulans application reduces the
duration of diarrhea, reduces the severity of abdominal pain, and normalizes
the composition of intestinal microflora.Bacillus coagulans efficiency
is identified also as hypocholesterolemic agents, as a means of
anti-inflammatory effect in the combination therapy of arthritis, in
combination with soya extracts for reducing menopause symptoms; by topical
application it was effective in vaginitis, stomatitis and dental caries. In
clinical studies proved the high safety of probiotics. Except spores Bacillus
coagulans, as part of the “Laktovit Forte” there are also present B9
and B12 vitamins in high doses, which are an essential component
for the early spore’s vegetation in the large intestine. These vitamins
stimulation phenomenon vegetation dispute has been confirmed experimentally,
as shown in the clinic acceleration by 1-2 days of initial clinical manifestations
of the effects of Bacillus coagulans, which is quite critical in acute
diarrhea microbial origin, abdominal pain and cramps.
Keywords: Bacillus
coagulans, pharmacology, biological properties, biological
activity, bacteriocins, review
|
17-37
|
|
|
ÌÎËÅÊÓËßÐÍÀß
ÝÂÎËÞÖÈß ÎÑÎÁÎ ÎÏÀÑÍÛÕ ÝÌÅÐÄÆÅÍÒÍÛÕ ÂÈÐÓÑÍÛÕ ÈÍÔÅÊÖÈÉ
Ïîïîâ
Í. Í., Êîëîòîâà Ò.Þ.
THE MOLECULAR EVOLUTION OF THE MOST DANGEROUS
EMERGING VIRUS INFECTIONS
Popov N. N., Kolotova T. Yu.
In this paper we
reviewed what is known about the emerging viruses, the hosts that they
originate in, and the molecular events that drive their emergence. When a
pathogen crosses over from animals to humans, or an existing human disease
suddenly increases in incidence, the infectious disease is said to be ‘emerging’.
Most of the emerging pathogens originate from nonhuman animal species which
has been termed natural reservoirs. The number of emerging infectious
diseases has increased over the last few decades, driven by both
anthropogenic and environmental factors such as population growth,
urbanization, global travel and trade, intensification of livestock
production. Now it has been believed that the emergence process may include
four steps. On the first step the exposure of the humans to a novel
virus occures. On the second step the subset of the viruses overcome
the cross-species barrier. Host shifts have resulted in multiple human
pandemics, such as HIV from chimps the H1N1, ‘‘spanish flu’’ from birds,
SARS-CoV and virus Ebola from bats. Then some viruses enables to transmit
from one human to another. And on the last step the viruses that are
sufficiently transmissible between humans cause outbreaks and become endemic
in human populations without the requirement of a natural reservoir. This
review aims to discuss the molecular mechanisms that govern virus
cross-species transmission and following stage, using the emergence of HIV,
SARS-CoV, virus Ebola and influenza virus A as the models.Populations of many
viruses harbour abundant genetic variability due to a combination of high
mutation, recombination or reassortation rates and large population sizes.
Mutations and recombinations has been associated with the increases in
virulence, the evasion of host immunity and the evolution of resistance to
antivirals. Genetic alterations in one species may results in the acquisition
of variations that allow them to overcome cross species barriers and infect
new hosts. Really, many recently emerged human diseases are caused by viruses
that display active recombination or reassortment. The continual shuffling of
genes of influenza A represents a example of the key role of reassortment for
the new virus emergence. Available data demonstrate the possible
origin of SARS-CoV from recombination of different bat SL-CoVs
viruses strains. However in other cases the emergence of a specific virus
cannot be directly attributed to its ability to recombine. For example,
although SIV recombines at a high rate in natural reservoirs, there is no
evidence that recombination assisted the cross-species transfer of the virus
from the chimpanzee into humans. But mutagenesis and recombination actively
shape the further molecular history of HIV in humans. Also it is not proved
that recombination precede the cross-species jump of the Ebola virus. In summary, the available data suggest that although
recombination, reassortment and mutagenesis is sometimes directly involved to
the process of cross-species transmission, it is not a necessary precursor to
successful viral emergence. Further investigations are required to reveal the
role of genetic change in the history of virus emergence. We believe
that comprehensive description of molecular evolution of new viruses has
led to a better understanding of the causes and predictability of infection
emergence.
Key words: emerging viruses, four stage of the
emergence, natural reservoir, recombination, reassotment, mutagenesis, HIV-1,
HIV-2, SIV, SARS-CoV, virus Ebola, influenza virus A
|
38-47
|
|
|
ÐÎËÜ
ÃÅÐÏÅѲÐÓÑ²Â Ó ÏÀÐÀÄÈÃ̲ ²ÍÔÅÊÖ²ÉÍÈÕ Ì²ÎÊÀÐÄÈÒ²Â
(îãëÿä
ë³òåðàòóðè)
Ïåðåìîò
Ñ.Ä., Ñì³ëÿíñüêà Ì.Â., Âîëÿíñüêèé À.Þ., Êàøïóð Í.Â.
THE
ROLE OF HERPESVIRUS IN THE PARADIGM OF INFECTIOUS MYOCARDITIS (REVIEW)
Peremot
S., Smilyanska M., Volyanskiy A., Kashpur N.
According
to the research of the last decade, there has been growth in the noncoronary
disease infarction, increased their share among the causes temporary or
persistent disability, disability and deaths. Among others myocarditis, which
constitute 11% of all diseases of the cardiovascular system and is
responsible for almost 20% of cases of sudden death in people physically
safe. The disease is an inflammatory damage to cardiomyocytes, which is
caused by direct action or indirectly through immune mechanisms of infectious
agents of bacterial, viral, protozoan nature, as well as chemical and
physical factors. The term "myocarditis" was first proposed I F
Soberheim in 1837 and in 1900. A. Fiedler described the myocardial injury and
justified the very concept of primary myocarditis. It is widely accepted that
myocarditis - natural complications of infectious diseases in which
etiological factor may be any infectious agent. However, at the present stage
bacterial pathogens give way to viral. Those viruses according to numerous
studies result in the development of myocarditis and consequently lead to the
development of myocardial dysfunction. Until recently, most were considered
cardiotropic ECHO viruses, Coxsackie group A, B, causing half of all cases of
viral myocarditis. However recently reviewed the role of enteroviruses in
favor of persistent virus and particularly the family Herpesviridae. The
significance in the etiology of myocarditis herpes simplex virus, human
herpes type 6, Epstein - Barr virus, cytomegalovirus. Published data indicate
that the development of viral myocarditis patients after serous
meningoencephalitis caused by the varicella-zoster virus. Widespread
herpesvirus diseases their tropism for endothelial cells and myocardium, the
capacity for long-term persistence in the body the opportunity to explain
virus inducted inflammatory damage to cardiomyocytes. Increased attention to
this issue recently linked with the present stage of the study of viral
disease characterized by the accumulation of new scientific data obtained
through the practice implemented highly informative diagnostic tests: ELISA,
immunofluorescence reactions and molecular biological methods. However,
despite scientific advances, today viral myocarditis remains less explored
disease, myocarditis virus inducted since if they are not diagnosed in the
acute phase of viral diseases remain without attention of clinicians in the
future are difficult to identify. According to the literature in 24 - 33% of
patients, myocarditis course may be clinically latent form and it is not
accurate data to determine the absolute frequency of myocarditis.
Endomyocardial biopsy (EMB) with immunohistochemical study of biopsy and
polymerase chain reaction, which recognized gold standard for diagnosis of
myocarditis, requires special equipment and highly qualified experts. In
addition, still debate that the EMB diagnostic value and feasibility of its
application in specific clinical situations and frequency of complications.
When myocarditis may be no correlation changes on ECG, biochemical and
clinical data, which significantly complicates diagnosis. Detect viruses in
the myocardium can direct method of myocardial biopsy and PCR. This
diagnostic importance only positive biopsy results, which in focal myocardial
lesions likely to be negative. Animal studies have shown that determine viral
replication in the myocardium is possible only in the first two weeks of the
disease, when symptoms of myocarditis may not be available or they are
minimal. It is shown that determination in serum pro-inflammatory cytokines
in myocarditis has a high diagnostic value and could compete with invasive
and instrumental methods of diagnosis, however, is not in the arsenal of
research laboratories and practical carrying it requires funds. Bring viral
myocarditis are also on the rise diagnostically meaningful titer virus
neutralizing antibodies in the serum of the patient. However, antibody titer
rises slowly, and often the results of this retrospective study have just
mentioned. More important is the study of the immunological status of
patients. Proof of inflammation in cardiomyocytes an imbalance of T-helper 1
and type 2, which defines the nature of the immune response in myocarditis.
Thus, we can say that today there are a number of non-invasive methods of
diagnosis of inflammatory lesions cardiomyocytes, which are highly
informative. In addition, there is intense accumulation of new scientific
data on the etiology and pathogenesis of viral myocarditis. So research aimed
at finding clear diagnostic criteria for verification of myocarditis, and
more widespread adoption of information and relatively safe methods of
diagnosis in clinical practice is especially important and will enhance
understanding of the significance of this disease in cardiovascular
continuum.
Key words: infectious myocarditis, herpes, ELISA, PCR, Endomyocardial biopsy, immunofluorescence
|
48-55
|
| |
ÅÊÑÏÅÐÈÌÅÍÒÀËÜͲ ÐÎÁÎÒÈ
Experimental papers
|
|
|
|
ÎÐÃÀͲÇÀÖ²ÉÍÎ-ÏÐÀÂβ ÄÎÑ˲ÄÆÅÍÍß ÎÁ²ÃÓ ÊÎÍÒÐÎËÜÎÂÀÍÈÕ Ë²ÊÀÐÑÜÊÈÕ ÇÀÑÎÁ²Â, ÙÎ Â̲ÙÓÞÒÜ ÄÅÊÑÒÐÎÏÐÎÏÎÊÑÈÔÅÍ
Øàïîâàëîâ Â.Â., Êîìàð Ë.Î.
ORGANIZATIONAL AND LEGAL STUDY OF THE
CIRCULATION OF THE COMBINED MEDICINES CONTAINING DEXTROPROPOXYPHENE
Shapovalov V.V., Komar L.A.
Introduction. Scientific studies in recent years in the field of
pharmaceutical law and forensic pharmacy indicate the existence of
cause-effect relationships of various kinds of addictive dependence and
illegal circulation of certain groups of combined medicines containing
controlled active pharmaceutical ingredients. Illegal production of narcotic
drugs and psychotropic substances from the combined drugs containing
controlled active pharmaceutical ingredients is of particular concern because
these medicines are in legal trade in the pharmaceutical sector of Ukraine
and used by patients in the treatment of pain of various etiologies, with
colds, dry cough and others. Purpose of the work is to carry out
organizational and legal studies of the legal circulation of combined
medicines containing controlled active pharmaceutical ingredient –
dextropropoxyphene. Materials and methods. Research material were
legal documents, instructions for medical use of combined medicines, forensic
and pharmaceutical practice, scientific literature sources and Internet
sites. In carrying out organizational and legal studies were used
conventional regulatory, documentary, retrospective, forensic and
pharmaceutical comparative graphical analysis methods. Results and discussion. In the course of the
organizational and legal research on the characteristics of the legal
handling controlled drugs that contain controlled active pharmaceutical
ingredient - dekstropropoksyfen found that to date its circulation is
regulated by the Order of the Ministry of healthcare of Ukraine from
19.07.2005. ¹360 «On approval of the rules of writing prescriptions and
requirements, orders for drugs and medical products, the Procedure for sale
of drugs and medical supplies from pharmacies and their structural
subdivisions and Instruction on storage, accounting and disposal of
prescription forms and claims-orders» According to
the requirements of this order all combined dekstropropoksyfen-containing
medicines should be discharged on a single prescription form F-1. To
streamline the rules trafficking controlled drugs, which include controlled
narcotic, have restrictions on their circulation stages of prescribing and
dispensing, which is associated with quantitative content of psychoactive
substances. Thus, for controlled medicines containing in its composition
dekstropropoksyfen amount set for delivery in one recipe is not more than 0.6
grams of narcotic drug (p. 1.22.2 Order). In order to control the traffic of
controlled medicines containing in its composition dekstropropoksyfen,
regardless of its quantity and dosage form, all dekstropropoksyfen-containing
medicines be subject-quantifiable in health care institutions that adopted
Annex 3 of this order. Conclusions. During the organizational and legal studies analyzed the current
pharmaceutical legislation-governing circulation of combined
dextropropoxyphene-containing medicines. The particularities of the
prescription of dextropropoxyphene-containing medicines were shown. On the
example of the medicine of "Spazmoleks" showed the change in the
regulatory framework of the combined circulation of the medicines and
changing availability dextropropoxyphene-containing medicines for forensic
and pharmaceutical criteria of "control mode". During the
organizational and legal research conducted a retrospective analysis of
prescription turnover dextropropoxyphene-containing medicines. According to
the analysis revealed that these drugs are sold from pharmacies and structural
units by the prescription F-1. Furthermore, according to existing
pharmaceutical legislation it is possible to write and dispense recipe of the
F-1 in combined dextropropoxyphene medicaments in an amount of more than 0.6
g in the case when packing products contains not more than 50 tablets. It was
fixed that today dextropropoxyphene-containing medicines are
subject-quantifiable. In the format of organizational and legal studies
analyzed the circulation of the prescription forms of F-1 in health care.
Keywords:
pharmaceutical law, forensic pharmacy, circulation, combined
medicines, controlled active pharmaceutical ingredients, dextropropoxyphene.
|
56-60
|
|
|
DEVELOPMENT OF TECHNIQUES FOR QUANTITATIVE ANALYSIS OF
LIME FLOWERS
Demyanenko D. V., Demyanenko V. G., Breusova S. V.
Introduction. The article is devoted to the development of techniques for
quantitative analysis of lime flower in order to make amendments to existing
pharmacopoeian monographs for this herbal drug. Lime inflorescences contain
lipophilic biologically active substances (BAS) causing notable antimicrobial
and anti-inflammatory effects and also more polar phenolic compounds with
antiulcer activity. Considering this, it’s necessary to regulate all these
groups of BAS quantitatively. Materials and methods. For this study six
batches of lime flowers harvested in 2008-2009 yrs. in Kharkiv, Rivno and
Zhitomir regions were used as crude herbal drug. Loss
on drying was determined by routine pharmacopoeian procedures. Total content
of lipophilic substances was determined gravimetrically after
Soxhlet extraction of samples 1, 5, 7 and 10 g in weight with methylene chloride, considering that by its extracting ability this solvent is
close to liquefied difluorochloromethane (freon R22) used by us for obtaining
of lipophilic complexes. The duration of complete
analytical extraction was determined by infusion of six 10 g assays of lime
flowers during 1, 2, 3, 4, 5, 6 hours, then quantity of lipophilic
extractives was revealed gravimetrically. Quantity of essential oil in lime
flowers was evaluated under the procedure of ÅÐ7, 2.8.12. Weight of the
herbal drug sample was 200 g, distillation rate – 2,5- 3,5 ml/min, volume of
distillation liquid (water) – 500 ml, volume of xylene in the graduated tube
– 0,50 ml. Total flavonoid content recalculated to
quercetin was determined after hydrolysis with acidified acetone, withdrawing
of flavonoid aglycones with ethylacetate and by further spectrophotometry of
their complexes with aluminium chloride. All quantitative determinations were
replicated five times for each assay. All
chemicals and reagents were of analytical grade.
Results and discussion. It was found that adequate
accuracy of the analysis of lipophilic extractives taken with methylene
chloride was achieved if assay weight is not less than 7 g: relative error
was less than 2 %. Study of extraction kinetics showed that after 4 hours
lipophilic substances soluble in methylene chloride were taken almost
completely. Analyzing 6 batches of lime flowers from different Ukrainian
regions, it was found that yield of total extractives taken with methylene
chloride did fall within insignificant limits – 1,86-2,26 %, that testifies
onto rather stable accumulation of these biologically active substances in
lime flowers even despite different climatic conditions. Essential oil
content varied in rather wide limits – 0,34-0,55 ml/kg of herbal drug and
considerably depended on harvest place: in the batches from Northwest of
Ukraine this value was less than in the Eastern ones. Year of harvesting had
less influence on quantity of essential oil in lime flowers. The relative
error of the quantitative determinations was within 4–8 %. Total
flavonoid content in the analyzed batches of lime flowers was considerably
variable (from 0,30 to 0,52 %) and depended mainly on place of harvesting,
and this crude herbal drug from the north-west of Ukraine (Rivno region)
showed the highest results among the analyzed samples. Besides, if consider
the lower limit regulated by the monograph of Belarusian Pharmacopoeia,
p. 370, then only one batch conformed to the norm (not less than 0,5 %).
Therefore it’s recommended to fix the lower limit 0,3 % for content of total
flavonoids in the corresponding monograph draft or analytical normative documentation.
The relative error of the quantitative determinations of flavonoids was
within 1,5–3,1 %. Conclusion. Six
batches of lime flowers harvested in various
regions of Ukraine in 2008 and 2009 yrs. were investigated. Based on the results obtained it is offered to regulate the
following quantity parameters in the amended monograph draft for lime flower:
total extractives taken with methylene chloride – not less than 1,8 %,
essential oil content – not less than 0,3 ml/kg, total flavonoid content
recalculated as quercetin - not less than 0,3 %.
Keywords: Lime
Flowers (Tilia cordata Mill.), Quantitative Analysis, Essential Oil,
Flavonoids, Difluorochloromethane.
|
61-66
|
|
|
ÂÈÇÓÀËÈÇÀÖÈß ÁÈÎÕÈÌÈ×ÅÑÊÎÉ
ÀÊÒÈÂÍÎÑÒÈ ÌÈÊÐÎÎÐÃÀÍÈÇÌÎÂ ÐÎÄÀ AEROCOCCUS ÂÈÄÀ AEROCOCCUS VIRIDANS
Êðåìåí÷óöêèé Ã.Í.,
Ñòåïàíñêèé Ä. À., Êîøåâàÿ È.Ï., Òóðëþí Ñ.À.
VISUALIZATION OF BIOCHEMICAL ACTIVITY OF
MICROORGANISMS GENUS AEROCOCCUS SPECIES AEROCOCCUS VIRIDANS
Kremenchutsky G.N., Stepansky D.O., Koshevaya I.P.,
Turlun S.A.
Introduction. Aerococci are
catalase-negative Gram-positive microorganisms, widespread in the
environment, in the cold-blooded microbiocenoses [1, 2] and warm-blooded
organisms [3]. Currently, there are seven species of the Aerococcus
genus [4]. Type A. viridans got its name as a result of greening blood
agar around the growing colonies. It was found that one of the products of A.
viridans growth is hydrogen peroxide, has an antagonistic effect on
various kinds of bacteria "in vitro" and "in vivo" [5].
It was subsequently found that hydrogen
peroxide and superoxide radical are produced as a result of NAD-independent
lactatoxidase [6,7] and piruvatoxidase functioning[8]. The
oxidative ability of A. viridans is a distinctive feature and allows
to visualize these properties using a specific indicator medium [9]. We have
developed an indicator that enables to visualize oxidation and reduction
properties of
aerococci. Material & methods. Auto-symbiotic
cultures of A. viridans was used
for studying of oxidase - reductase
activity, inoculated from human body, an industrial strain of A. viridans
167,
used for the preparation of "A-bacterin", culture of Aureobasidium
pullulans B5, isolated from the soil and having glucose oxidase activity
[10] Designed
indicating medium were also tested in the inoculation of aerococci crops,
having lactatoxidase activity of biomaterials from birds and mammals. As a
basis for the indicating media (IM) IM1 media was selected with following
composition (g per 1 liter of water) Iodide /
potassium 26.0 Soluble starch 10.0 Nutrient
agar 30.0
For
visualization of oxidase-reductase activity of aerococci acellular components
IM4 was developed based on IM3, in which distilled water after double
purification was used instead of tap water and highly purified agar-agar was
used instead of standard nutrient agar. Results & discussion. IM1 is
used to test the oxidative properties of aerococci crops. IM manifests the
appearance of a dark purple color, after processing the surface of cups with
10% sulfuric acid. Dark purple areas with lactatoxidase activity in the
growth zone of the culture are clearly visible. IM2 with high content of KJ
can be used for isolation of aerococci colonies from contaminated biological
material.
IM3
with sodium selenite at a concentration of 1 g / l was used to visualize the
reductase activity of microorganisms. Selenium recovered with the advent of
the red color in the areas of crop growth and the colonies while growth of
aerococcuses.
Nutrient
indicator medium IM3, containing an increased concentration of KJ, can be
used for isolation and studying the oxidizing ability of different
microorganisms which produce hydrogen peroxide in the oxidation of biological
substrates. IM4 allows us to study the biochemical activity of the
enzyme complex (EC) obtained by ultrasound (US) from washed thoroughly
biomass of aerococcuses [11] and biological substrates. Conclusion.
1.
Indicator nutrient mediums IM1, IM2, containing the KJ and soluble starch
allows to visualize the oxidizing power of aerococci and isolate them
together with another microorganisms from contaminated biological products
(water, air, soil, biological fluids). 2. The indicator
nutrient media IM3 allows (simultaneously with oxidase activity of
microorganism) to visualize reductase activity in the reduction of selenium
with classification on biological types. 3. Minimal
(hungry) IM4 allows us to observe the interaction between aerococci enzyme
complex and substrates of oxidation and reduction, with further extrapolation
of the results to the role of aerococci in microbiotope of host organism. The
proposed indicator media can be used for microbiological and genetic studies,
microbiological determination of amino acids, vitamins and nitrogenous bases.
Key words: aerococcus viridans, selective mediums, cultivation, stain.
|
67-72
|
| |
ÎÑÎÁËÈÂÎÑÒ² ÏÅÐÅÁ²ÃÓ
ÅϲÄÅ̲×ÍÎÃÎ ÏÐÎÖÅÑÓ Â²Ë-²ÍÔÅÊÖ²¯ Ó ÕÀÐʲÂÑÜÊ²É ÎÁËÀÑÒ²
ͳêîëàºâà Ë.Ã., Ìàéñòàò Ò.Â.,
Ïîäàâàëåíêî À.Ï., Êóù Ä.Â.
COURSE FEATURES EPIDEMIC PROCESS HIV INFECTION IN
KHARKIV REGION
Nikolaeva
L.G., Majstat T.V., Podavalenko A.P., Kusch D.V.
Introduction.
In
the context of the transformation of the spheres of human living epidemic
HIV-infection continues. According to the intensity of the epidemic process
of HIV-infection, Ukraine takes one of the first places among the European
countries. The epidemic process of the infection is concentrated mainly on
the high-risk groups, and there is uneven prevalence. Besides in most cases
this distribution can not be explained by the social and economic
characteristics of certain territories. Kharkiv region belongs to the
territory of Ukraine with the lowest prevalence level of HIV-infection.
Though in terms of the social and economic crisis due to hostilities in the
east of the country, which the region borders, the epidemic situation may
significantly become worse. Work objective: to study the peculiarities of the
course of the epidemic process of HIV-infection for the period from 1987 till
2015 in Kharkiv region that will improve the epidemiological surveillance of
the infection and develop appropriate preventive measures in modern
conditions. Material & methods. The studies were conducted in
Kharkiv region, which is a big industrial and administrative center. The city
of Kharkiv is located at the crossroads of drug trafficking from Asia and
Russia. The reportings and analytics of
the Kharkiv regional center for prevention and control of AIDS and the
Ministry of Health of Ukraine for the period of 1987 – 2015 were used in the
research. The analysis of incidence of HIV prevalence, structure of
transmission routes and sex-age groups were carried out using descriptive and
evaluative and analytical ways of epidemiological research method. Results
& discussion. During 1987 – 2015 in Kharkiv region there were
officially registered 7868 cases of HIV-infection what was equal to 4.0 % of
the registered cases in Ukraine. Since 1996 a marked upward tendency of the
incidence of HIV infection in Kharkiv region (growth rate – +7.0 %), and on
the whole in Ukraine (growth rate – +14.0 %). Herewith
of incidence of HIV-infection in the region were lower than on the
whole in Ukraine (accordingly 2.4 – 23.7 and 10.6 – 47.1 per 100 000
population). Almost all of the administrative territories of Kharkiv region
have been involved into the epidemic process of HIV-infection, but in
districts of the region the incidence of HIV-infection, AIDS and mortality
were in 1.4 – 2.7 times higher than in Kharkiv itself. The measures directed
at the prevention of HIV-infection in the groups of risk were actively being
taken during the supervision in the region. Due to the collaboration of the
executive authorities and local government, departmental structures, medical
community and public organizations directed at the suspension
of HIV-infection/AIDS epidemic in the region we managed to stabilize a
little an epidemical situation on HIV-infection. For the period of 1987 –
2015 in the region there was defined the increase in the number of the
infected women (from 12.9 % to 41.0 %) and the decrease of the number of men
(from 87.1 % to 59.0 %) what led to the change of the ratio of the number of
women with the number of men in accordance with 1:7 (1996) and 1:1.5 (2015).
There were adult patients with HIV-infection (79.5 – 84.9 %) in 4 - 5 times
more than children under the age of 14 (15.1 – 20.5 %). The largest
proportion of HIV-infected people in the age group of 25 – 49 years (60.0 –
72.2 %) and the lowest – 15 – 17 years (0.1 – 1.0 %). In different periods of
the current epidemic process of HIV-infection the ratio of parenteral, sexual
and vertical routes of transmission considerably changed. At the beginning of
the epidemic the incidence level of HIV-infection has been significantly
affected by the drugs spreading and an increase in vulnerable groups of
injecting drug users. Thus, in 1996 the part of the sexual route of
transmission was equal to 5.7 % cases, whereas the part of parenteral one
consists of 77.1 % cases. Taking effective preventive measures against drug
abuse has led to the decrease in the incidence of HIV-infection among this
group of risk and changes of transmission routes. In 2015 in the structure of
the leading transmission routes there were (22.6 ± 1.8) % of parenteral and
(56.9 ± 2.1) % of sexual cases (p<0.05). These data indicate that the
implementation tract infection due to injecting drug use leads to a
concentrated stage of the HIV epidemic. At the same time the increase in the
proportion of sexual transmission increase in the number of infected women
indicate a threat to the output of the epidemic risk groups to the general
set of the population. Conclusions. 1. The incidence
of HIV-infection in the region was in several times lower than on the whole
in Ukraine (accordingly 2.4 - 23.7 and 10.6 - 47.1 per 100 000 population).
2. Carried out research in the region revealed the peculiarities of the
epidemic process of HIV-infection. So the level of growth of newly registered
cases of HIV-infection from 0.1 per 100 000 population in 1995 to 20.5 per
100 000 population in 2015 was set (the growth rate was +7.0 %); a
gradual change in the sexual spectrum of HIV-infected people (women from 12.9
% to 41.0 % and men from 87.1 % to 59.0 %) and the structure of the leading
transmission routes (parenteral from 77.1 % to 22.6% and sexual from 5.7 % to
59.6 %); involvement in the epidemic process of all age groups with a
predominance of the most working-age population 25 – 49 years. 3. The HIV
epidemic is concentrated on the most vulnerable groups of population, but
there is a risk of generalized spreading of HIV among the population. 4.
Epidemiological surveillance of HIV infection must be adapted to the local
epidemiological conditions, and preventive measures aimed at the timely
detection of infection cases and the suspension of the epidemic.
Keywords: human
immunodeficiency virus (HIV), incidence, social groups of observation,
transmission route
|
73-79
|
| |